High-resolution gamma-camera for molecular breast imaging: First clinical results

Area of Science:

• Medical Imaging
• Nuclear Medicine
• Oncology

Background:

• Molecular breast imaging (MBI) with standard gamma-cameras is valuable for indeterminate mammograms and dense breasts, but struggles with detecting cancers smaller than 1 cm.
• Early detection of small breast cancers is crucial for improving treatment outcomes and the clinical utility of radiopharmaceutical imaging.
• High-resolution dedicated breast imaging cameras offer improved sensitivity for small lesions.

Purpose of the Study:

• To evaluate the efficacy of a high-resolution dedicated breast imaging camera (Lumagem 3200S) for detecting small breast cancers.
• To compare the detection rates of small malignant lesions using a dedicated MBI camera versus a standard gamma-camera.
• To assess the specificity of both imaging systems in differentiating benign from malignant lesions.

Main Methods:

• Prospective evaluation of 29 patients with BI-RADS category III and IV lesions ≤1 cm.
• Comparison of imaging results obtained with a conventional gamma-camera and a dedicated high-resolution Lumagem 3200S camera.
• Analysis of sensitivity and specificity for detecting malignant and benign lesions.

Main Results:

• The dedicated Lumagem camera detected all (100%) malignant lesions, while the standard gamma-camera detected only 44% (4 out of 9).
• Both the standard and dedicated cameras demonstrated high specificity, correctly identifying 95% (19 out of 20) of benign lesions.
• The dedicated camera successfully visualized small cancers (<1 cm) that were missed by conventional imaging.

Conclusions:

• Molecular breast imaging with the dedicated Lumagem camera significantly enhances the detection of small breast cancers.
• This technology improves diagnostic accuracy in patients with indeterminate mammographic findings.
• The high-resolution dedicated camera shows promise for early breast cancer identification, especially for small, subtle lesions.